Allied Biotech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	129.46	100.94	97.41	146.74	13.04
Depreciation & Amortization	61	61.94	69.45	71.76	65.24
Loss (Gain) From Sale of Assets	0.86	-	-	1.59	-
Provision & Write-off of Bad Debts	-	-	-	2	-
Other Operating Activities	4.16	-2.7	-16.62	31.82	-9.13
Change in Accounts Receivable	-6.7	-21.69	8.62	-16.2	13.7
Change in Inventory	16.13	73.94	-5	-88.39	-22.84
Change in Accounts Payable	3.9	-1.4	-10.69	-0.41	10.7
Change in Unearned Revenue	-0.91	-2.04	3.39	-0.34	0.88
Change in Other Net Operating Assets	9.25	14.8	-8.95	15.7	0.83
Operating Cash Flow	217.13	223.79	137.62	164.27	72.43
Operating Cash Flow Growth	-2.98%	62.62%	-16.23%	126.81%	21.77%
Capital Expenditures	-89.51	-26.81	-47.91	-54.66	-49.99
Sale of Property, Plant & Equipment	-	-	-	0.11	-
Investment in Securities	-	97.37	6.98	273.57	-130.95
Other Investing Activities	0.02	-0.02	-0.01	-	-
Investing Cash Flow	-89.49	70.55	-40.94	219.02	-180.94
Short-Term Debt Issued	-	170	-	-	265
Long-Term Debt Issued	-	58.87	-	107.68	-
Total Debt Issued	-	228.87	-	107.68	265
Short-Term Debt Repaid	-200	-	-20	-390	-
Long-Term Debt Repaid	-24.04	-82.99	-24.17	-132.32	-24.76
Total Debt Repaid	-224.04	-82.99	-44.17	-522.32	-24.76
Net Debt Issued (Repaid)	-224.04	145.88	-44.17	-414.64	240.24
Common Dividends Paid	-96.02	-81.42	-114.46	-47.68	-76.12
Other Financing Activities	0.73	0.48	0.3	0.32	0.12
Financing Cash Flow	-319.33	64.94	-158.33	-462	164.24
Foreign Exchange Rate Adjustments	2.44	0.56	0.39	1.07	-1.82
Net Cash Flow	-189.25	359.84	-61.26	-77.64	53.91
Free Cash Flow	127.62	196.98	89.71	109.62	22.44
Free Cash Flow Growth	-35.21%	119.58%	-18.16%	388.49%	744.88%
Free Cash Flow Margin	15.02%	24.41%	12.45%	15.29%	3.32%
Free Cash Flow Per Share	1.32	2.04	0.94	1.14	0.23
Cash Interest Paid	17.33	13.58	12.87	11.65	11.06
Cash Income Tax Paid	30.73	32.55	40.65	5.66	13.88
Levered Free Cash Flow	48.27	135.02	33.04	17.52	65.85
Unlevered Free Cash Flow	59.1	143.74	41.13	24.86	72.88
Change in Working Capital	21.67	63.61	-12.63	-89.63	3.28

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.